A study to evaluate the safety and tolerability of the covalent phosphoinositide-3-kinase (PI3K)-alpha Inhibitor, TOS-358, in adult subjects with select solid tumorsMarwan Fakih,Davendra P. Sohal,Navid Hafez,Jordan D. Berlin, Kimberly Hari, Ovid C. TrifanCANCER RESEARCH（2023）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
